Show Summary Details
Page of

Chlamydia trachomatis 

Chlamydia trachomatis
Chlamydia trachomatis

G. Ingrid J. G. Rours

and Margaret R. Hammerschlag

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 02 March 2021

The estimated incidence of Chlamydia trachomatis infection is over 100 million cases globally and almost 1 million in the United States. Infection with C. trachomatis tends to be asymptomatic and of long duration. If a pregnant woman has active infection during delivery, the infant may acquire the infection, which can result in conjunctivitis or pneumonia. The most effective method of controlling perinatal C. trachomatis infection is the screening and treatment of pregnant women. Identification of infected mothers offers the opportunity to provide treatment for their sexual partners to help prevent reinfection and Chlamydia-associated morbidity in them, in addition to preventing morbidity during pregnancy and perinatal infection. Further research on prevention, especially in resource-limited settings, is most important. The implementation of prenatal screening and treatment is feasible now and will greatly reduce morbidity in pregnant women, their sexual partners, and their infants.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.